跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COVALONGUARD FOAM - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
COVALONGUARD FOAM
Authorized
STANDARD
COVALONGUARD FOAM
Covalon Technologies Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
6d140fa2720670ec
Company
Covalon Technologies Inc
Type
Standard
Approval Details
Approval Id
6d140fa2720670ec
Drug Approval Canada Name
COVALONGUARD FOAM
Product Name
COVALONGUARD FOAM
Status
Cancelled Pre Market
Status Date
2021-08-31
Din
02499762
Drug Class
Human
Dosage Form
Foam
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:04.92
Atc Original
D08AJ01 BENZALKONIUM
Atc Name
d 08 aj 01
Aig Number
0104993016
Company Name
Covalon Technologies Inc
Company Address
UNIT 5, 1660 Tech Ave, Mississauga, Ontario, Canada, L4W 5S7
Company Detail Path
/organization/covalon-technologies-inc
Company Information
Pharmaceutical Company Name
Covalon Technologies Inc
Country Name
Canada
Province Name
Ontario
City Name
mississauga,ontario,country_ca
Address
5-1660 Tech Ave
Active Ingredients
BENZALKONIUM CHLORIDE
0.13 % / W/V
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
6d140fa2720670ec
Type
Standard
Back to Health Canada Approvals